{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:03:02Z","timestamp":1791518582711,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Rotterdam"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00423-019-01755-4","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T21:26:31Z","timestamp":1549488391000},"page":"71-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis"],"prefix":"10.1007","volume":"404","author":[{"name":"on behalf of the Dutch Hyperparathyroid Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. R.","family":"Dulfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Y.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Y.","family":"van der Plas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F.","family":"Engelsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J. M. Nieveen","family":"van Dijkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kruijff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. I.","family":"Rotmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. H. J.","family":"van Eijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"van Ginhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"1755_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913\u2013921","journal-title":"Clin J Am Soc Nephrol"},{"key":"1755_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"FWM Tentori","year":"2015","unstructured":"Tentori FWM, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10:98\u2013109","journal-title":"Clin J Am Soc Nephrol"},{"key":"1755_CR3","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208\u20132218","journal-title":"J Am Soc Nephrol"},{"key":"1755_CR4","first-page":"5","volume":"18","author":"M Cozzolino","year":"2005","unstructured":"Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A (2005) Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol 18:5\u20138","journal-title":"J Nephrol"},{"key":"1755_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516\u20131525","journal-title":"N Engl J Med"},{"key":"1755_CR6","unstructured":"Kidney Disease: Improving Global Outcomes CKDMBDWG (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl :S1\u2013130"},{"key":"1755_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92:26\u201336","journal-title":"Kidney Int"},{"key":"1755_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","volume":"33","author":"P Evenepoel","year":"2013","unstructured":"Evenepoel P (2013) Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. Semin Nephrol 33:191\u2013203","journal-title":"Semin Nephrol"},{"key":"1755_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1399-0012.2010.01287.x","volume":"25","author":"JB Copley","year":"2011","unstructured":"Copley JB, Wuthrich RP (2011) Therapeutic management of post-kidney transplant hyperparathyroidism. Clin Transpl 25:24\u201339","journal-title":"Clin Transpl"},{"key":"1755_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","volume":"19","author":"P Evenepoel","year":"2004","unstructured":"Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19:1281\u20131287","journal-title":"Nephrol Dial Transplant"},{"key":"1755_CR11","doi-asserted-by":"crossref","unstructured":"Jeon HJ, Kim YJ, Kwon HY et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int (12):376\u2013377","DOI":"10.1111\/j.1432-2277.2012.01564.x"},{"key":"1755_CR12","first-page":"111","volume":"17","author":"MC Gioviale","year":"2012","unstructured":"Gioviale MC, Bellavia M, Damiano G, Lo Monte AI (2012) Post-transplantation tertiary hyperparathyroidism. Ann Transplant 17:111\u2013119","journal-title":"Ann Transplant"},{"key":"1755_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","volume":"21","author":"OI Egbuna","year":"2007","unstructured":"Egbuna OI, Taylor JG, Bushinsky DA, Zand MS (2007) Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transpl 21:558\u2013566","journal-title":"Clin Transpl"},{"key":"1755_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.transproceed.2005.12.065","volume":"38","author":"FN Ozdemir","year":"2006","unstructured":"Ozdemir FN, Afsar B, Akgul A, Usluogullari C, Akcay A, Haberal M (2006) Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 38:480\u2013482","journal-title":"Transplant Proc"},{"key":"1755_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/01.tp.0000230130.50451.78","volume":"82","author":"S Akaberi","year":"2006","unstructured":"Akaberi S, Lindergard B, Simonsen O, Nyberg G (2006) Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Transplantation 82:749\u2013752","journal-title":"Transplantation"},{"key":"1755_CR16","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1111\/ajt.12425","volume":"13","author":"P Perrin","year":"2013","unstructured":"Perrin P, Caillard S, Javier RM, Braun L, Heibel F, Borni-Duval C, Muller C, Olagne J, Moulin B (2013) Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. Am J Transplant 13:2653\u20132663","journal-title":"Am J Transplant"},{"key":"1755_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1365-2362.2007.01874.x","volume":"37","author":"RP Wuthrich","year":"2007","unstructured":"Wuthrich RP, Martin D, Bilezikian JP (2007) The role of calcimimetics in the treatment of hyperparathyroidism. Eur J Clin Investig 37:915\u2013922","journal-title":"Eur J Clin Investig"},{"key":"1755_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5414\/CNP74433","volume":"74","author":"J Aalten","year":"2010","unstructured":"Aalten J, Wetzels JF, Hoitsma AJ (2010) Continuation of cinacalcet immediately after renal transplantation: a prospective cohort study. Clin Nephrol 74:433\u2013439","journal-title":"Clin Nephrol"},{"key":"1755_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bcp.2010.04.002","volume":"80","author":"EM Brown","year":"2010","unstructured":"Brown EM (2010) Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR). Biochem Pharmacol 80:297\u2013307","journal-title":"Biochem Pharmacol"},{"key":"1755_CR20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/TP.0b013e31826c3968","volume":"94","author":"JB Cohen","year":"2012","unstructured":"Cohen JB, Gordon CE, Balk EM, Francis JM (2012) Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis. Transplantation 94:1041\u20131048","journal-title":"Transplantation"},{"key":"1755_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","volume":"42","author":"G Eknoyan","year":"2003","unstructured":"Eknoyan G, Levin A, Levin NW (2003) Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:1\u2013201","journal-title":"Am J Kidney Dis"},{"key":"1755_CR22","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/ndt\/gfm044","volume":"22","author":"P Evenepoel","year":"2007","unstructured":"Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transplant 22:1730\u20131737","journal-title":"Nephrol Dial Transplant"},{"key":"1755_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00423-012-1025-6","volume":"398","author":"P Riss","year":"2013","unstructured":"Riss P, Asari R, Scheuba C, Niederle B (2013) Current trends in surgery for renal hyperparathyroidism (RHPT) - an international survey. Langenbeck's Arch Surg 398:121\u2013130","journal-title":"Langenbeck's Arch Surg"},{"key":"1755_CR24","first-page":"699","volume":"142","author":"V Costa-Hong","year":"2007","unstructured":"Costa-Hong V, Jorgetti V, Gowdak LHW, Moyses RMA, Krieger EM, De Lima JJG (2007) Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery (USA) 142:699\u2013703","journal-title":"Surgery (USA)"},{"key":"1755_CR25","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"CG Evolve Trial Investigator","year":"2012","unstructured":"Evolve Trial Investigator CG, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482\u20132494","journal-title":"N Engl J Med"},{"key":"1755_CR26","doi-asserted-by":"publisher","first-page":"e1001436","DOI":"10.1371\/journal.pmed.1001436","volume":"10","author":"SC Palmer","year":"2013","unstructured":"Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GFM (2013) Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med 10:e1001436","journal-title":"PLoS Med"},{"key":"1755_CR27","doi-asserted-by":"crossref","unstructured":"Cruzado JMMP, Torregrosa JV, Taco O, Mast R, Gomez-Vaguero C, Polo C, Revuelta I, Francos J, Torras J, Garcia-Barrasa A, Bestard O, Grinyo JMA (2015) Randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol","DOI":"10.1681\/ASN.2015060622"},{"key":"1755_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"1755_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/TP.0000000000000583","volume":"99","author":"H Pihlstrom","year":"2015","unstructured":"Pihlstrom H, Dahle DO, Mjoen G et al (2015) Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation 99:351\u2013359","journal-title":"Transplantation"},{"key":"1755_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1245\/s10434-016-5450-6","volume":"24","author":"WY Plas van der","year":"2017","unstructured":"van der Plas WY, Engelsman AF, Ozyilmaz A et al (2017) Impact of the introduction of calcimimetics on timing of parathyroidectomy in secondary and tertiary hyperparathyroidism. Ann Surg Oncol 24:15\u201322","journal-title":"Ann Surg Oncol"},{"key":"1755_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/BF01665309","volume":"15","author":"M Rothmund","year":"1991","unstructured":"Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15:745\u2013750","journal-title":"World J Surg"},{"key":"1755_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.surg.2015.08.039","volume":"159","author":"I Lou","year":"2016","unstructured":"Lou I, Schneider DF, Leverson G, Foley D, Sippel R, Chen H (2016) Parathyroidectomy is underused in patients with tertiary hyperparathyroidism after renal transplantation. Surgery 159:172\u2013179","journal-title":"Surgery"},{"key":"1755_CR33","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/bjs.10554","volume":"104","author":"RR Dulfer","year":"2017","unstructured":"Dulfer RR, Franssen GJH, Hesselink DA, Hoorn EJ, van Eijck CHJ, van Ginhoven TM (2017) Systematic review of surgical and medical treatment for tertiary hyperparathyroidism. Br J Surg 104:804\u2013813","journal-title":"Br J Surg"},{"key":"1755_CR34","doi-asserted-by":"publisher","first-page":"S168","DOI":"10.1053\/ajkd.2001.27432","volume":"38","author":"Y Tominaga","year":"2001","unstructured":"Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y, Numano M, Tanaka Y, Inagaki H, Watanabe I, Hachisuka T, Takagi H (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38:S168\u2013S171","journal-title":"Am J Kidney Dis"},{"key":"1755_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/SLA.0b013e3181728a2d","volume":"248","author":"FCO Triponez","year":"2008","unstructured":"Triponez FCO, Vanrenthergem Y, Evenepoel P (2008) Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 248:18\u201330","journal-title":"Ann Surg"},{"key":"1755_CR36","doi-asserted-by":"crossref","unstructured":"Chiroli S, Mattin C, Belozeroff V, Perrault L, Mitchell D, Gioni I (2012) Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study. BMC Nephrol 13","DOI":"10.1186\/1471-2369-13-140"},{"key":"1755_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1053\/j.ajkd.2007.03.009","volume":"49","author":"R Narayan","year":"2007","unstructured":"Narayan R, Perkins RM, Berbano EP, Yuan CM, Neff RT, Sawyers ES, Yeo FE, Vidal-Trecan GM, Abbott KC (2007) Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 49:801\u2013813","journal-title":"Am J Kidney Dis"},{"key":"1755_CR38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jval.2015.08.007","volume":"18","author":"V Belozeroff","year":"2015","unstructured":"Belozeroff V, Chertow GM, Graham CN, Dehmel B, Parfrey PS, Briggs AH (2015) Economic evaluation of cinacalcet in the United States: the EVOLVE trial. Value Health 18:1079\u20131087","journal-title":"Value Health"},{"key":"1755_CR39","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"J Cunningham","year":"2005","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68:1793\u20131800","journal-title":"Kidney Int"},{"key":"1755_CR40","doi-asserted-by":"crossref","unstructured":"Nicolas Verheyen SP, Eller K, Kienreich K, Astrid Fahrleitner-Pammer BP, Ritz E, Tomaschitz A (2013) Cinacalcet hydrochloride for the treatment of hyperparathyroidism. Expert Opin Pharmacother: 793\u2013806","DOI":"10.1517\/14656566.2013.777041"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-019-01755-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-019-01755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-019-01755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T19:07:30Z","timestamp":1581016050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-019-01755-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1755"],"URL":"https:\/\/doi.org\/10.1007\/s00423-019-01755-4","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"6 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study from the medical ethical committee boards of all centers was retrieved. According to the decision of the medical ethical committees, no informed consent was required. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}